SteadyMed Ltd. (NASDAQ:STDY) is scheduled to be posting its 6/30/2017 quarterly earnings results before the market opens on Monday, August 14th. Analysts expect SteadyMed to post earnings of ($0.32) per share for the quarter.
SteadyMed Ltd. (NASDAQ STDY) opened at 6.20 on Friday. The firm’s market capitalization is $156.06 million. SteadyMed Ltd. has a 52-week low of $2.25 and a 52-week high of $9.70. The stock’s 50 day moving average price is $6.35 and its 200 day moving average price is $5.58.
Separately, Zacks Investment Research downgraded SteadyMed from a “hold” rating to a “sell” rating in a research report on Tuesday, June 6th.
SteadyMed Ltd. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of various therapeutic product candidates. Its primary focus is to obtain approval in the United States for the sale of Trevyent for the treatment of pulmonary arterial hypertension (PAH).
What are top analysts saying about SteadyMed Ltd.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for SteadyMed Ltd. and related companies.